Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3271 | 1920 | 35.0 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
380 | 3 | CROHNS DISEASE//ULCERATIVE COLITIS//INFLAMMATORY BOWEL DISEASE | 31889 |
3271 | 2 | 6 MERCAPTOPURINE//THIOPURINE METHYLTRANSFERASE//AZATHIOPRINE | 1920 |
3737 | 1 | 6 MERCAPTOPURINE//THIOPURINE METHYLTRANSFERASE//AZATHIOPRINE | 1920 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | 6 MERCAPTOPURINE | authKW | 2475801 | 15% | 55% | 284 |
2 | THIOPURINE METHYLTRANSFERASE | authKW | 2305683 | 8% | 92% | 157 |
3 | AZATHIOPRINE | authKW | 2168305 | 23% | 31% | 434 |
4 | THIOPURINE S METHYLTRANSFERASE | authKW | 1369639 | 5% | 90% | 96 |
5 | THIOPURINES | authKW | 1201618 | 7% | 55% | 138 |
6 | TPMT | authKW | 1106533 | 4% | 84% | 83 |
7 | MERCAPTOPURINE | authKW | 686912 | 4% | 60% | 72 |
8 | 6 THIOGUANINE NUCLEOTIDES | authKW | 685139 | 2% | 96% | 45 |
9 | 6 THIOGUANINE | authKW | 566055 | 4% | 47% | 75 |
10 | THIOGUANINE NUCLEOTIDES | authKW | 287031 | 1% | 95% | 19 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 11488 | 24% | 0% | 456 |
2 | Pharmacology & Pharmacy | 5194 | 32% | 0% | 605 |
3 | Medical Laboratory Technology | 1808 | 5% | 0% | 102 |
4 | Oncology | 719 | 12% | 0% | 229 |
5 | Hematology | 646 | 6% | 0% | 122 |
6 | Pediatrics | 372 | 6% | 0% | 111 |
7 | Toxicology | 247 | 4% | 0% | 80 |
8 | Medicine, General & Internal | 208 | 7% | 0% | 125 |
9 | Dermatology | 199 | 3% | 0% | 57 |
10 | Chemistry, Analytical | 180 | 6% | 0% | 109 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNIDAD TOXICOL MOL HEPAT | 122319 | 1% | 77% | 10 |
2 | PURINE | 104582 | 1% | 26% | 25 |
3 | PEDIAT ONCOL SE NETHERLANDS | 63608 | 0% | 100% | 4 |
4 | GASTROENTEROL GERIATR INTERNAL INTENS CARE | 35778 | 0% | 75% | 3 |
5 | HAEMATOL ONCOL OUTPATIENT | 35778 | 0% | 75% | 3 |
6 | INFLAMMATORY BOWEL DIS MED GASTROENT | 31804 | 0% | 100% | 2 |
7 | INFLAMMATORY DIS BIOL THER EUT PROGRAM | 31804 | 0% | 100% | 2 |
8 | PHARMACOTHER IE | 31804 | 0% | 100% | 2 |
9 | SECT CLIN HAEMATOL ONCOL | 31804 | 0% | 100% | 2 |
10 | SECT MED PHARMACOL | 26497 | 0% | 33% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THERAPEUTIC DRUG MONITORING | 12342 | 3% | 1% | 54 |
2 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 11371 | 4% | 1% | 68 |
3 | JOURNAL OF CROHNS & COLITIS | 9851 | 1% | 2% | 25 |
4 | PHARMACOGENETICS | 8102 | 1% | 2% | 22 |
5 | FALK SYMPOSIUM | 7697 | 2% | 1% | 37 |
6 | PHARMACOGENOMICS | 5569 | 1% | 1% | 25 |
7 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 3232 | 2% | 1% | 41 |
8 | INFLAMMATORY BOWEL DISEASES | 2930 | 1% | 2% | 11 |
9 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 2920 | 2% | 1% | 33 |
10 | PHARMACOGENETICS AND GENOMICS | 2723 | 1% | 1% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 6 MERCAPTOPURINE | 2475801 | 15% | 55% | 284 | Search 6+MERCAPTOPURINE | Search 6+MERCAPTOPURINE |
2 | THIOPURINE METHYLTRANSFERASE | 2305683 | 8% | 92% | 157 | Search THIOPURINE+METHYLTRANSFERASE | Search THIOPURINE+METHYLTRANSFERASE |
3 | AZATHIOPRINE | 2168305 | 23% | 31% | 434 | Search AZATHIOPRINE | Search AZATHIOPRINE |
4 | THIOPURINE S METHYLTRANSFERASE | 1369639 | 5% | 90% | 96 | Search THIOPURINE+S+METHYLTRANSFERASE | Search THIOPURINE+S+METHYLTRANSFERASE |
5 | THIOPURINES | 1201618 | 7% | 55% | 138 | Search THIOPURINES | Search THIOPURINES |
6 | TPMT | 1106533 | 4% | 84% | 83 | Search TPMT | Search TPMT |
7 | MERCAPTOPURINE | 686912 | 4% | 60% | 72 | Search MERCAPTOPURINE | Search MERCAPTOPURINE |
8 | 6 THIOGUANINE NUCLEOTIDES | 685139 | 2% | 96% | 45 | Search 6+THIOGUANINE+NUCLEOTIDES | Search 6+THIOGUANINE+NUCLEOTIDES |
9 | 6 THIOGUANINE | 566055 | 4% | 47% | 75 | Search 6+THIOGUANINE | Search 6+THIOGUANINE |
10 | THIOGUANINE NUCLEOTIDES | 287031 | 1% | 95% | 19 | Search THIOGUANINE+NUCLEOTIDES | Search THIOGUANINE+NUCLEOTIDES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MOON, W , LOFTUS, EV , (2016) REVIEW ARTICLE: RECENT ADVANCES IN PHARMACOGENETICS AND PHARMACOKINETICS FOR SAFE AND EFFECTIVE THIOPURINE THERAPY ININFLAMMATORY BOWEL DISEASE.ALIMENTARY PHARMACOLOGY & THERAPEUTICS. VOL. 43. ISSUE 8. P. 863 -883 | 170 | 87% | 3 |
2 | CHOUCHANA, L , NARJOZ, C , BEAUNE, P , LORIOT, MA , ROBLIN, X , (2012) REVIEW ARTICLE: THE BENEFITS OF PHARMACOGENETICS FOR IMPROVING THIOPURINE THERAPY IN INFLAMMATORY BOWEL DISEASE.ALIMENTARY PHARMACOLOGY & THERAPEUTICS. VOL. 35. ISSUE 1. P. 15 -36 | 175 | 85% | 65 |
3 | CABALEIRO, T , ROMAN, M , GISBERT, JP , ABAD-SANTOS, F , (2012) UTILITY OF ASSESSING THIOPURINE S-METHYLTRANSFERASE POLYMORPHISMS BEFORE AZATHIOPRINE THERAPY.CURRENT DRUG METABOLISM. VOL. 13. ISSUE 9. P. 1277 -1293 | 198 | 93% | 3 |
4 | VAN ASSELDONK, DP , DE BOER, NKH , PETERS, GJ , VELDKAMP, AI , MULDER, CJ , VAN BODEGRAVEN, AA , (2009) ON THERAPEUTIC DRUG MONITORING OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE; PHARMACOLOGY, PHARMACOGENOMICS, DRUG INTOLERANCE AND CLINICAL RELEVANCE.CURRENT DRUG METABOLISM. VOL. 10. ISSUE 9. P. 981-997 | 163 | 88% | 6 |
5 | BLAKER, PA , ARENAS-HERNANDEZ, M , MARINAKI, AM , SANDERSON, JD , (2012) THE PHARMACOGENETIC BASIS OF INDIVIDUAL VARIATION IN THIOPURINE METABOLISM.PERSONALIZED MEDICINE. VOL. 9. ISSUE 7. P. 707 -725 | 137 | 88% | 3 |
6 | GISBERT, JP , GOMOLLON, F , (2008) THIOPURINE-INDUCED MYELOTOXICITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A REVIEW.AMERICAN JOURNAL OF GASTROENTEROLOGY. VOL. 103. ISSUE 7. P. 1783 -1800 | 113 | 91% | 80 |
7 | LENNARD, L , (2014) IMPLEMENTATION OF TPMT TESTING.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 77. ISSUE 4. P. 704 -714 | 88 | 95% | 15 |
8 | TEML, A , SCHAEFFELER, E , HERRLINGER, KR , KLOTZ, U , SCHWAB, M , (2007) THIOPURINE TREATMENT IN INFLAMMATORY BOWEL DISEASE - CLINICAL PHARMACOLOGY AND IMPLICATION OF PHARMACOGENETICALLY GUIDED DOSING.CLINICAL PHARMACOKINETICS. VOL. 46. ISSUE 3. P. 187-208 | 133 | 73% | 71 |
9 | AL HADITHY, AFY , DE BOER, NKH , DERIJKS, LJJ , ESCHER, JC , MULDER, CJJ , BROUWERS, JRBJ , (2005) THIOPURINES IN INFLAMMATORY BOWEL DISEASE: PHARMACOGENETICS, THERAPEUTIC DRUG MONITORING AND CLINICAL RECOMMENDATIONS.DIGESTIVE AND LIVER DISEASE. VOL. 37. ISSUE 4. P. 282 -297 | 129 | 83% | 56 |
10 | SAHASRANAMAN, S , HOWARD, D , ROY, S , (2008) CLINICAL PHARMACOLOGY AND PHARMACOGENETICS OF THIOPURINES.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 64. ISSUE 8. P. 753 -767 | 100 | 80% | 144 |
Classes with closest relation at Level 2 |